Public Company News

KEDING Introduces True⁺ Panels, Strengthening Its Position as a Comprehensive Premium Interior Surface Solutions Brand

NEW TAIPEI CITY, Jan. 6, 2026 /PRNewswire/ -- Meeting the surging demand for high-performance building materials globally, a new generation of interior materials are set to launch in January, 2026. KD True⁺ Panels and KD SPC Flooring will debut acrossSouth East Asia market targeting commercial, ...

2026-01-06 14:55 3436

Agoda reveals: Perhentian Islands is Malaysia's top emerging destination

KUALA LUMPUR, Malaysia, Jan. 6, 2026 /PRNewswire/ -- Perhentian Islands has emerged as the fastest growing destination for attracting international travelers inMalaysia, according to digital travel platform Agoda's latest New Horizons ranking. The travel platform further reveals Sitiawan to be th...

2026-01-06 10:30 3175

Innodisk Unveils the New "AI on Dragonwing" Computing Series with the First EXMP-Q911 COM-HPC Mini Module Powered by Qualcomm's SoC

The module integrates a high-efficiency AI SoC with in-house software and peripherals to serve as a powerful Edge AI platform. TAIPEI, Jan. 6, 2026 /PRNewswire/ -- Innodisk, a leading global AI solution provider, announced the launch of its newAI on Dragonwing computing series, developed in coll...

2026-01-06 10:00 2720

Hyundai Motor Group Announces AI Robotics Strategy to Lead Human-Centered Robotics Era at CES 2026

* Hyundai Motor Group debuts real-world human-centered AI Robotics at CES 2026 * The Group to secure optimal capabilities, including its expansive Group-wide value chain and product portfolio, to lead the Physical AI industry * The Group to also connect global Physical AI industries, including...

2026-01-06 09:54 3156

Everest Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference

SHANGHAI, Jan. 6, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced thatIan Woo, President and Chief Fina...

2026-01-06 07:58 3436

Supermicro Announces Support for Upcoming NVIDIA Vera Rubin NVL72, HGX Rubin NVL8 and Expanded Rack-Scale Manufacturing Capacity for Liquid-Cooled AI Solutions

Data Center Building Block Solutions® (DCBBS) and Advanced Direct Liquid Cooling (DLC) Technology with Supermicro US Based In-House Design/Manufacturing Accelerate Time to Deployment of Next Generation Liquid-cooled AI Infrastructure SAN JOSE, Calif., Jan. 6, 2026 /PRNewswire/ -- Supermicro, Inc....

2026-01-06 07:00 7214

BOE and RT-RK Collaborate to Deliver Next-Generation Android TV with Advanced AI Capabilities powered by Qualcomm Technologies

LAS VEGAS, Jan. 6, 2026 /PRNewswire/ -- BOE Technology Group Co., Ltd.(SZSE: 000725) (SZSE: 200725), and RT-RK bring the latestAndroid TV experience to BOE's newest state-of-the-art smart TV platform, powered by the Qualcomm Dragonwing™ QCS8550 Processor. This collaborative effort combines display...

2026-01-06 01:00 2922

LG ELECTRONICS UNVEILS ITS APPROACH TO "AI IN ACTION"

How LG Electronics Brings AI to Life Across Homes, Mobility and Infrastructure With Affectionate Intelligence News Summary: * LG Electronics introduced its approach to "AI in Action," built on three strategic pillars: device excellence, orchestrated eco-system and expansion of AI-driven solut...

2026-01-06 00:58 2846

NYSE Content Advisory: Pre-Market Update + NYSE Becomes Exclusive Stock Exchange Partner of America250

NEW YORK, Jan. 5, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-Market Update + NYSE Becomes Exclusive...

2026-01-05 21:58 7368

YY Group Expands into Egypt's USD 20 Billion Hospitality Market

YY Group scales its MENA presence, introducing AI-driven workforce solutions to Egypt's booming tourism sector. SINGAPORE, Jan. 5, 2026 /PRNewswire/ -- YY Group Holding Limited (NASDAQ: YYGH) ("YY Group" or the "Company"), a global leader in on-demand workforce solutions and integrated facilitie...

2026-01-05 21:30 6819

Kelun-Biotech Receives Investigational New Drug Approval for ITGB6-Targeted ADC SKB105 from the NMPA

CHENGDU, China, Jan. 5, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that its Investigational New Drug (IND) application for SKB105 (also known as CR-003), an internally developed integrin beta-6 (ITGB6)-targeted ant...

2026-01-05 20:00 3219

Sisram Medical Reports Completion of NIFDC Testing for DAXXIFY in China

Marking a Key Milestone Toward Market Launch and Strengthening Sisram's Premium Aesthetics Portfolio HONG KONG, Jan. 5, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the"Group"), a global wellness group off...

2026-01-05 17:36 2581

Kelun-Biotech Announces Breakthrough Therapy Designation Granted in China for Sacituzumab Tirumotecan (sac-TMT) in Combination with Immunotherapy Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC

CHENGDU, China, Jan. 5, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company," 6990.HK) today announced that its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) (佳泰莱®) in combination wi...

2026-01-05 17:29 3532

Autoliv and Tensor Introduce World's First Foldable Steering Wheel for autonomous driving

STOCKHOLM, Jan. 5, 2026 /PRNewswire/ -- Autoliv, Inc. (NYSE: ALV) and (SSE: ALIVsdb), the worldwide leader in automotive safety systems, and Tensor, a leading innovator in personal autonomous vehicles, have co-developed the world's first foldable steering wheel for the Tensor Robocar. With dual ...

2026-01-05 15:28 2459

Agoda Reveals Growing Interest for Year-End Domestic Travel with Kuala Lumpur at the Forefront in 2025

All top five domestic destinations experienced positive growth in accommodation searches compared to previous year SINGAPORE, Jan. 5, 2026 /PRNewswire/ -- Malaysian travelers are increasingly eyeing domestic destinations for December travel, reveals digital travel platform Agoda. The insight is ...

2026-01-05 14:00 3827

Manulife Hong Kong Launches Genesis Centurion Insurance Plan and Prestige Achiever Insurance Plan

Two new participating life insurance savings plans designed to empower financial well-being and meet evolving customer needs for flexibility and growth HONG KONG, Jan. 5, 2026 /PRNewswire/ -- Manulife Hong Kong today announced the launch of two new participating life insurance savings plans — Gen...

2026-01-05 13:42 6135

Amorepacific Showcases Innovative Technologies at CES 2026

Award-Winning Technology and Samsung Electronics Collaboration on Display SEOUL, South Korea, Jan. 5, 2026 /PRNewswire/ -- Amorepacific participates in CES 2026, the world's largest IT and consumer electronics trade show taking placeJanuary 6 to 9 (local time) in Las Vegas, Nevada.

2026-01-05 12:14 4224

C&R Research, the 'K-Clinical Hub', Strengthens Partnerships in Indonesia

Accelerating Indonesia Collaboration through Global Clinical Capabilities SEOUL, South Korea, Jan. 5, 2026 /PRNewswire/ -- C&R Research, founded in 1997 as Korea's first full-service Contract Research Organization (CRO), has played a pivotal role in advancing the Korean clinical trial industry an...

2026-01-05 10:00 4613

Hyundai Motor Group Executive Chair Chung Presents 2026 Vision: Customer-Focused Transformation and AI-Driven Ecosystem Collaboration

* Executive Chair Chung emphasizes customer-focused transformation and ecosystem strengthening to navigate evolving market dynamics and lead new industry standards * Presents strategic priorities, including agile decision-making, ecosystem competitiveness, and bold collaboration with diverse ...

2026-01-05 09:10 3735

Ascletis Announces U.S. FDA IND Clearance for 13-Week Phase II Study of Its Oral Small Molecule GLP-1, ASC30, in Participants with Diabetes

-The Phase II study for diabetes is a 13-week, randomized, double-blind, placebo-controlled and multi-center study to evaluate the efficacy, safety, and tolerability of ASC30 in participants with diabetes. Enrollment is expected to begin in the first quarter of 2026. -ASC30 demonstrated placebo-...

2026-01-05 08:10 3084
1234567 ... 1664